Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine whether treatment with armodafinil will
provide improvements in prefrontal cortical activation in patients with OSAHS (Obstructive
Sleep Apnea/Hypopnea Syndrome) who have residual sleepiness despite receiving nCPAP therapy.